Novel method to prevent severe postoperative pancreatic fistula caused by lipolysis
Journal of Hepato-Biliary-Pancreatic Sciences · 2025
DOI: 10.1002/jhbp.12128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Naoto Nakamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Pancreatic Fistula, Postoperative Complications, Lipolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Although several prophylactic strategies have been developed for postoperative pancreatic fistula (POPF), research on its severe form is few. Recently, it has been reported that severe POPF can be caused by intraabdominal lipolysis. This study aimed to establish a rat model of severe POPF by combining pancreatic juice leakage and lipolysis and to develop a prophylactic strategy for POPF.
Methods
Sprague–Dawley rats were subjected to pancreatic transection to induce pancreatic juice leakage (PT group). Autologous fat tissue was thermally treated to prepare a fat solution, which was intraperitoneally administered to the rats in the PT group (PT + F group). A water‐solubilized lipase inhibitor (cetilistat) was administered intraperitoneally to the rats in the PT + F group. A polyethylene glycol‐based hydrogel (PEG‐HG) formulation of water‐solubilized cetilistat was equally administered. Ascitic and serum biochemical tests, including free fatty acids (FFA) levels, macroscopic or microscopic examinations, and survival analyses, were performed.
Results
In the PT + F group, significantly elevated ascitic and serum FFA levels and serum inflammatory cytokine levels were observed 24 h postoperatively ( p < .001), and the survival rate was significantly exacerbated ( p < .0001). Intraperitoneal administration of water‐solubilized cetilistat resulted in reduced inflammation and improved outcomes. Although PEG hydrogel itself did not improve blood parameters or survival outcomes, the incorporation of water‐solubilized cetilistat into the PEG‐HG enabled similar improvement.
Conclusion
Intraperitoneal administration of water‐solubilized cetilistat prevented severe inflammation and multiple failures associated with severe POPF. The incorporation of water‐solubilized cetilistat into the PEG‐HG is a promising delivery system for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Surgery, Fujita Health University, Toyoake, Japan.
- Department of Surgery, Kurashiki Central Hospital, Kurashiki, Japan.
- Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
ORCID-Profile: Naoto Nakamura, Akitada Yogo, Yuichiro Uchida, Toshihiko Masui, Etsuro Hatano
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Nakamura, N., Nagai, K., Kaneda, A., Yogo, A., Kasai, Y., Anazawa, T., Uchida, Y., Masui, T., Tabata, Y., & Hatano, E. (2025). Novel method to prevent severe postoperative pancreatic fistula caused by lipolysis. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12128
Vancouver
Nakamura N, Nagai K, Kaneda A, Yogo A, Kasai Y, Anazawa T, et al. Novel method to prevent severe postoperative pancreatic fistula caused by lipolysis. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.12128
BibTeX
@article{Nakamura2025,
author = {Nakamura, Naoto and Nagai, Kazuyuki and Kaneda, Akihiro and Yogo, Akitada and Kasai, Yosuke and Anazawa, Takayuki and Uchida, Yuichiro and Masui, Toshihiko and Tabata, Yasuhiko and Hatano, Etsuro},
title = {Novel method to prevent severe postoperative pancreatic fistula caused by lipolysis},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2025},
doi = {10.1002/jhbp.12128}
}
EUVIMED